Evaluation of Heparin as a potentially interfering substance [Bioanalytics]

posted by Monic  – India, 2019-09-11 14:04 (382 d 17:17 ago) – Posting: # 20584
Views: 1,794

(edited by Monic on 2019-09-11 14:16)

Hi everyone,

Is it required to evaluate the interaction of "heparin" with your analyte of interest during concomitant medication effect as a part of bio-analytical method validation parameter?
since heparin is infused during blood collection to prevent formation of blood clots in clinical phase.

Note: The anticoagulant used for the blood collection in vacutainer is K2EDTA.


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

 Admin contact
21,080 posts in 4,397 threads, 1,468 registered users;
online 6 (0 registered, 6 guests [including 2 identified bots]).
Forum time: Monday 07:21 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz